Steam vs. pill: new study tests One-Time procedure for prostate troubles

NCT ID NCT07169773

Completed Disease control Sponsor: khaled Abdelsattar Gad Ibrahim Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compared two treatments for men with an enlarged prostate causing urinary symptoms. One group received a procedure called Rezum, which uses water vapor (steam) to shrink prostate tissue. The other group took a daily medication called tamsulosin. The trial enrolled 94 men and measured symptom scores, urine flow, and quality of life over 12 months. The goal was to see which approach works better and is safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Rezum (water vapor thermal ablation) and tamsulosin
What this could lead to: If Rezum works better than tamsulosin, it could offer a one-time procedure to ease urinary symptoms from an enlarged prostate, reducing the need for daily pills.
What could go wrong: This is a small, completed trial with 94 men. Results may not apply to everyone, and Rezum is a procedure with risks like any surgery. It is not a cure; symptoms may return over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE HYPERPLASIA

Contacts and locations

Locations

The Armed Forces College of Medicine (AFCM

Cairo, Nozha, 4470351, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.